LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA

Clinical trials for LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Can a Dual-Action antibody boost chemo against bile duct cancer?

Disease control Not yet recruiting

This trial is testing whether adding ivonescimab to standard chemotherapy (gemcitabine and cisplatin) works better than the usual chemo-immunotherapy combination for people with advanced biliary tract cancer. Ivonescimab is a special antibody that targets two proteins: one that h…

Matched conditions: LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA

Phase: PHASE2, PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA

Get alerted when new LOCALLY ADVANCED BILIARY TRACT ADENOCARCINOMA trials appear

Can a Dual-Action antibody boost chemo against bile duct cancer?